Altay F - Search Results

1

Combined Effects of Zein Nanofiber Coating Containing Laurel (Laurus nobilis) and Air Fryer Cooking on Quality Properties of Fish Fillets during Cold Storage.

Ceylan Z, Meral R, Alav A, Torusdağ GB, Bildik F, Altay F. Ceylan Z, et al. Among authors: altay f. ACS Omega. 2024 Feb 14;9(8):8940-8946. doi: 10.1021/acsomega.3c06318. eCollection 2024 Feb 27. ACS Omega. 2024. PMID: 38434834 Free PMC article.

2

Gelatin nanofibers with black elderberry, Au nanoparticles and SnO₂ as intelligent packaging layer used for monitoring freshness of Hake fish.

Cetinkaya T, Bildik F, Altay F, Ceylan Z. Cetinkaya T, et al. Among authors: altay f. Food Chem. 2024 Mar 30;437(Pt 1):137843. doi: 10.1016/j.foodchem.2023.137843. Epub 2023 Nov 2. Food Chem. 2024. PMID: 37931424

3

Emulsion electrospinning of zein nanofibers with carotenoid microemulsion: Optimization, characterization and fortification.

İnan-Çınkır N, Ağçam E, Altay F, Akyıldız A. İnan-Çınkır N, et al. Among authors: altay f. Food Chem. 2024 Jan 1;430:137005. doi: 10.1016/j.foodchem.2023.137005. Epub 2023 Jul 27. Food Chem. 2024. PMID: 37527575

4

Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational study.

Şencan İ, Karabay O, Altay FA, Yıldız SS, Şimşek H, Gözükara MG, Kuzi S, Karlıdağ GE, Kaya Ş, Kul G, Türkoğlu E, Sezer BE, Korkmaz N, Kaya SY, Sayar MS, Bulut D, Akgül F, Çağ Y, Ağalar C, Dursun ZB, Taşbakan M, Aydemir SŞ, Seyman D, Yıldırım M, Habip Z, Altın N, Uzar H, Bektaş B, Engin DÖ, Erdem HA, Sürme S. Şencan İ, et al. Among authors: altay fa. Turk J Med Sci. 2023 Jun;53(3):780-790. doi: 10.55730/1300-0144.5641. Epub 2023 Jun 19. Turk J Med Sci. 2023. PMID: 37476892 Free PMC article.

5

The Experience of our Center in Patients Undergoing Insulin Degludec/ Insulin Aspart Co-formulation Therapy.

Altay FP, Farzaliyeva A, İyidir ÖT, Bozkuş Y, Kırnap NG, Kut A, Nar A, Tütüncü NB. Altay FP, et al. Endocr Metab Immune Disord Drug Targets. 2023;23(6):826-831. doi: 10.2174/1871530323666221124112413. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 36424790

6

Serum thrombin-activatable fibrinolysis inhibitor levels and its relation with pathogenesis and bleeding and prognosis in patients with Crimean Congo hemorrhagic fever.

Altin N, Altay FA, Albayrak M, Sahingoz SO, Sencan I. Altin N, et al. Among authors: altay fa. J Med Virol. 2023 Jan;95(1):e28182. doi: 10.1002/jmv.28182. Epub 2022 Oct 8. J Med Virol. 2023. PMID: 36175009

7

Pathological substrate of memory impairment in multiple system atrophy.

Miki Y, Tanji K, Shinnai K, Tanaka MT, Altay F, Foti SC, Strand C, Sasaki T, Kon T, Shimoyama S, Furukawa T, Nishijima H, Yamazaki H, Asi YT, Bettencourt C, Jaunmuktane Z, Tada M, Mori F, Mizukami H, Tomiyama M, Lashuel HA, Lashley T, Kakita A, Ling H, Lees AJ, Holton JL, Warner TT, Wakabayashi K. Miki Y, et al. Among authors: altay f. Neuropathol Appl Neurobiol. 2022 Dec;48(7):e12844. doi: 10.1111/nan.12844. Epub 2022 Aug 12. Neuropathol Appl Neurobiol. 2022. PMID: 35906771

8

Ectopic TSH-secreting Pituitary Adenoma in Nasopharyngeal Region.

Altay FP, Kulaksızoğlu M, Fenkci SM, Yalçın N, Sağtaş E. Altay FP, et al. Acta Endocrinol (Buchar). 2021 Oct-Dec;17(4):521-527. doi: 10.4183/aeb.2021.521. Acta Endocrinol (Buchar). 2021. PMID: 35747874 Free PMC article.

9

A Case Report of Concurrent Graves' Disease and Subacute Thyroiditis Following SARS-CoV-2 Vaccination: An Autoimmune/Inflammatory Syndrome (ASIA).

Taşkaldıran I, Altay FP, Bozkuş Y, İyidir ÖT, Nar A, Tütüncü NB. Taşkaldıran I, et al. Among authors: altay fp. Endocr Metab Immune Disord Drug Targets. 2023;23(2):242-246. doi: 10.2174/1871530322666220621101209. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 35726807

10

A Case Report of Conversion from Hashimoto's Thyroiditis to Graves' Disease in Type 1 Diabetic Patient Following the COVID-19 Vaccination.

Taşkaldıran I, Altay FP, Bozkuş Y, İyidir ÖT, Nar A, Tütüncü NB. Taşkaldıran I, et al. Among authors: altay fp. Endocr Metab Immune Disord Drug Targets. 2023;23(3):405-409. doi: 10.2174/1871530322666220616104058. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 35713143

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page